{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:14:12Z","timestamp":1789456452827,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Xiamen Municipal Health Commission"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-026-05047-6","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:34:33Z","timestamp":1782491673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of early anti-VEGF Therapy anatomical response with renal function and OCT biomarkers in diabetic macular edema"],"prefix":"10.1186","volume":"26","author":[{"given":"Huixiang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5240-3915","authenticated-orcid":false,"given":"Yuanzhi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"5047_CR1","doi-asserted-by":"publisher","first-page":"16012","DOI":"10.1038\/nrdp.2016.12","volume":"2","author":"TY Wong","year":"2016","unstructured":"Wong TY, Cheung CMG, Larsen M, Sharma S, Sim\u00f3 R. Diabetic retinopathy. Nat Reviews Disease Primers. 2016;2:16012. https:\/\/doi.org\/10.1038\/nrdp.2016.12.","journal-title":"Nat Reviews Disease Primers"},{"key":"5047_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2024.12.020","author":"JI Lim","year":"2025","unstructured":"Lim JI, Kim SJ, Bailey ST, Kovach JL, Vemulakonda GA, Ying G, et al. Diabetic Retinopathy Preferred Practice Pattern\u00ae. Ophthalmology. 2025. https:\/\/doi.org\/10.1016\/j.ophtha.2024.12.020.","journal-title":"Ophthalmology"},{"key":"5047_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/jamaophthalmol.2017.6565","volume":"136","author":"NM Bressler","year":"2018","unstructured":"Bressler NM, Beaulieu WT, Glassman AR, Blinder KJ, Bressler SB, Jampol LM, et al. Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2018;136:257\u201369. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.6565.","journal-title":"JAMA Ophthalmol"},{"key":"5047_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/medicina59030629","volume":"59","author":"Y-C Chang","year":"2023","unstructured":"Chang Y-C, Huang Y-T, Hsu AY, Meng P-P, Lin C-J, Lai C-T, et al. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema after Ranibizumab Injections. Med (Mex). 2023;59:629. https:\/\/doi.org\/10.3390\/medicina59030629.","journal-title":"Med (Mex)"},{"key":"5047_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/02713683.2023.2182745","volume":"48","author":"S Zhang","year":"2023","unstructured":"Zhang S, Chen Y, Wang L, Li Y, Tang X, Liang X, et al. Design and Baseline Data of the Diabetes Registration Study: Guangzhou Diabetic Eye Study. Curr Eye Res. 2023;48:591\u20139. https:\/\/doi.org\/10.1080\/02713683.2023.2182745.","journal-title":"Curr Eye Res"},{"key":"5047_CR6","doi-asserted-by":"publisher","first-page":"031194","DOI":"10.1136\/bmjopen-2019-031194","volume":"9","author":"X Zhuang","year":"2019","unstructured":"Zhuang X, Cao D, Yang D, Zeng Y, Yu H, Wang J, et al. Association of diabetic retinopathy and diabetic macular oedema with renal function in southern Chinese patients with type 2 diabetes mellitus: a single-centre observational study. BMJ OPEN. 2019;9:031194. https:\/\/doi.org\/10.1136\/bmjopen-2019-031194.","journal-title":"BMJ OPEN"},{"key":"5047_CR7","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, Panageas KS. How To Build and Interpret a Nomogram for Cancer Prognosis. J Clin Oncol. 2008;26:1364\u201370. https:\/\/doi.org\/10.1200\/JCO.2007.12.9791.","journal-title":"J Clin Oncol"},{"key":"5047_CR8","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1136\/bjophthalmol-2020-318690","volume":"106","author":"K Liu","year":"2022","unstructured":"Liu K, Wang H, He W, Ye J, Song Y, Wang Y, et al. Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study. Br J Ophthalmol. 2022;106:1436\u201343. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-318690.","journal-title":"Br J Ophthalmol"},{"key":"5047_CR9","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/IAE.0000000000000770","volume":"36","author":"KH Seo","year":"2016","unstructured":"Seo KH, Yu S-Y, Kim M, Kwak HW, VISUAL AND MORPHOLOGIC OUTCOMES OF INTRAVITREAL, RANIBIZUMAB FOR DIABETIC MACULAR EDEMA BASED ON OPTICAL COHERENCE TOMOGRAPHY PATTERNS. Retina. 2016;36:588\u201395. https:\/\/doi.org\/10.1097\/IAE.0000000000000770.","journal-title":"Retina"},{"key":"5047_CR10","doi-asserted-by":"publisher","first-page":"7879691","DOI":"10.1155\/2017\/7879691","volume":"2017","author":"T Kaiho","year":"2017","unstructured":"Kaiho T, Oshitari T, Tatsumi T, Takatsuna Y, Arai M, Shimizu N, et al. Efficacy of One-Year Treatment with Aflibercept for Diabetic Macular Edema with Practical Protocol. Biomed Res Int. 2017;2017:7879691. https:\/\/doi.org\/10.1155\/2017\/7879691.","journal-title":"Biomed Res Int"},{"key":"5047_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ajo.2016.09.012","volume":"172","author":"VH Gonzalez","year":"2016","unstructured":"Gonzalez VH, Campbell J, Holekamp NM, Kiss S, Loewenstein A, Augustin AJ, et al. Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data. Am J Ophthalmol. 2016;172:72\u20139. https:\/\/doi.org\/10.1016\/j.ajo.2016.09.012.","journal-title":"Am J Ophthalmol"},{"key":"5047_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/aos.13935","volume":"97","author":"V Bonfiglio","year":"2019","unstructured":"Bonfiglio V, Reibaldi M, Pizzo A, Russo A, Macchi I, Faro G, et al. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers. Acta Ophthalmol (copenh). 2019;97:540\u20134. https:\/\/doi.org\/10.1111\/aos.13935.","journal-title":"Acta Ophthalmol (copenh)"},{"key":"5047_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/bjophthalmol-2021-319587","volume":"107","author":"SK Szeto","year":"2023","unstructured":"Szeto SK, Hui VWK, Tang FY, Yang D, Sun ZH, Mohamed S, et al. OCT-based biomarkers for predicting treatment response in eyes with centre-involved diabetic macular oedema treated with anti-VEGF injections: a real-life retina clinic-based study. Br J Ophthalmol. 2023;107:525\u201333. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-319587.","journal-title":"Br J Ophthalmol"},{"key":"5047_CR14","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.ophtha.2015.03.024","volume":"122","author":"A Das","year":"2015","unstructured":"Das A, McGuire PG, Rangasamy S. Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets. Ophthalmology. 2015;122:1375\u201394. https:\/\/doi.org\/10.1016\/j.ophtha.2015.03.024.","journal-title":"Ophthalmology"},{"key":"5047_CR15","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ophtha.2010.02.031","volume":"117","author":"MJ Elman","year":"2010","unstructured":"Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, et al. Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema. Ophthalmology. 2010;117:1064\u201377. https:\/\/doi.org\/10.1016\/j.ophtha.2010.02.031.","journal-title":"Ophthalmology"},{"key":"5047_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1001\/jamaophthalmol.2015.5346","volume":"134","author":"SB Bressler","year":"2016","unstructured":"Bressler SB, Ayala AR, Bressler NM, Melia M, Qin H, Ferris FL, et al. Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment. JAMA Ophthalmol. 2016;134:278\u201385. https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.5346.","journal-title":"JAMA Ophthalmol"},{"key":"5047_CR17","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1001\/archophthalmol.2012.1107","volume":"130","author":"SB Bressler","year":"2012","unstructured":"Bressler SB, Qin H, Beck RW, Chalam KV, Kim JE, Melia M, et al. Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab. Arch Ophthalmol. 2012;130:1153\u201361. https:\/\/doi.org\/10.1001\/archophthalmol.2012.1107.","journal-title":"Arch Ophthalmol"},{"key":"5047_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.sjopt.2010.05.001","volume":"24","author":"FA Warid Al-Laftah","year":"2010","unstructured":"Warid Al-Laftah FA, Elshafie M, Alhashimi M, Pai A, Farouq M. Pretreatment clinical variables associated with the response to intravitreal bevacizumab (Avastin) injection in patients with persistent diabetic macular edema. Saudi J Ophthalmol. 2010;24:133\u20138. https:\/\/doi.org\/10.1016\/j.sjopt.2010.05.001.","journal-title":"Saudi J Ophthalmol"},{"key":"5047_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cyto.2008.03.011","volume":"43","author":"K Pawlak","year":"2008","unstructured":"Pawlak K, Mysliwiec M, Pawlak D. Oxidative stress, phosphate and creatinine levels are independently associated with vascular endothelial growth factor levels in patients with chronic renal failure. Cytokine. 2008;43:98\u2013101. https:\/\/doi.org\/10.1016\/j.cyto.2008.03.011.","journal-title":"Cytokine"},{"key":"5047_CR20","first-page":"3463","volume":"49","author":"L Akduman","year":"2008","unstructured":"Akduman L, Chiranand P, Smith C. Diabetic Macular Edema Decrease by OCT After Dialysis. Investig Ophthalmol Vis Sci. 2008;49:3463\u20133463.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"5047_CR21","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577\u201389. https:\/\/doi.org\/10.1056\/NEJMoa0806470.","journal-title":"N Engl J Med"},{"key":"5047_CR22","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2337\/diacare.15.7.815","volume":"15","author":"MI Harris","year":"1992","unstructured":"Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4\u20137 year before clinical diagnosis. Diabetes Care. 1992;15:815\u20139. https:\/\/doi.org\/10.2337\/diacare.15.7.815.","journal-title":"Diabetes Care"},{"key":"5047_CR23","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000313820","volume":"224","author":"MI Roh","year":"2010","unstructured":"Roh MI, Kim JH, Kwon OW. Features of Optical Coherence Tomography Are Predictive of Visual Outcomes after Intravitreal Bevacizumab Injection for Diabetic Macular Edema. Ophthalmologica. 2010;224:374\u201380. https:\/\/doi.org\/10.1159\/000313820.","journal-title":"Ophthalmologica"},{"key":"5047_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/jop.2011.0070","volume":"28","author":"P-C Wu","year":"2012","unstructured":"Wu P-C, Lai C-H, Chen C-L, Kuo C-N. Optical Coherence Tomographic Patterns in Diabetic Macula Edema Can Predict the Effects of Intravitreal Bevacizumab Injection as Primary Treatment. J Ocul Pharmacol Ther. 2012;28:59\u201364. https:\/\/doi.org\/10.1089\/jop.2011.0070.","journal-title":"J Ocul Pharmacol Ther"},{"key":"5047_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ophtha.2010.03.035","volume":"118","author":"T Murakami","year":"2011","unstructured":"Murakami T, Nishijima K, Sakamoto A, Ota M, Horii T, Yoshimura N. Foveal Cystoid Spaces Are Associated with Enlarged Foveal Avascular Zone and Microaneurysms in Diabetic Macular Edema. Ophthalmology. 2011;118:359\u201367. https:\/\/doi.org\/10.1016\/j.ophtha.2010.03.035.","journal-title":"Ophthalmology"},{"key":"5047_CR26","doi-asserted-by":"publisher","first-page":"6710","DOI":"10.1167\/iovs.09-5064","volume":"51","author":"GG De\u00e1k","year":"2010","unstructured":"De\u00e1k GG, Bolz M, Ritter M, Prager S, Benesch T, Schmidt-Erfurth U, et al. A Systematic Correlation between Morphology and Functional Alterations in Diabetic Macular Edema. Invest Ophth Vis Sci. 2010;51:6710\u20134. https:\/\/doi.org\/10.1167\/iovs.09-5064.","journal-title":"Invest Ophth Vis Sci"},{"key":"5047_CR27","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/0002-9394(81)90638-3","volume":"92","author":"BS Fine","year":"1981","unstructured":"Fine BS, Brucker AJ. Macular Edema and Cystoid Macular Edema. Am J Ophthalmol. 1981;92:466\u201381. https:\/\/doi.org\/10.1016\/0002-9394(81)90638-3.","journal-title":"Am J Ophthalmol"},{"key":"5047_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.sjopt.2016.12.006","volume":"31","author":"A Ozkaya","year":"2017","unstructured":"Ozkaya A, Alkin Z, Karakucuk Y, Karatas G, Fazil K, Gurkan Erdogan M, et al. Thickness of the retinal photoreceptor outer segment layer in healthy volunteers and in patients with diabetes mellitus without retinopathy, diabetic retinopathy, or diabetic macular edema. Saudi J Ophthalmol. 2017;31:69\u201375. https:\/\/doi.org\/10.1016\/j.sjopt.2016.12.006.","journal-title":"Saudi J Ophthalmol"},{"key":"5047_CR29","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1167\/iovs.12-10503","volume":"54","author":"D-H Lee","year":"2013","unstructured":"Lee D-H, Kim JT, Jung D-W, Joe SG, Yoon YH. The relationship between foveal ischemia and spectral-domain optical coherence tomography findings in ischemic diabetic macular edema. Invest Ophthalmol Vis Sci. 2013;54:1080\u20135. https:\/\/doi.org\/10.1167\/iovs.12-10503.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5047_CR30","first-page":"8216150","volume":"2019","author":"AHA Elhamid","year":"2019","unstructured":"Elhamid AHA. Quantitative Assessment of Outer Retinal Layer and Photoreceptor Outer Segment Layer and Their Relation to Visual Acuity in Diabetic Macular Edema. J Ophthalmol. 2019;2019:8216150.","journal-title":"J Ophthalmol"},{"key":"5047_CR31","doi-asserted-by":"publisher","first-page":"722","DOI":"10.4103\/IJO.IJO_903_23","volume":"72","author":"A Sardana","year":"2024","unstructured":"Sardana A, Singh K, Singh A, Singh VK. Optical coherence tomography biomarkers DROL, PROS, SND, hyperreflective walls of foveal cystoid spaces as predictors of central macular thickness and visual acuity in diabetic macular edema treated with intravitreal ranibizumab. Indian J Ophthalmol. 2024;72:722\u20137. https:\/\/doi.org\/10.4103\/IJO.IJO_903_23.","journal-title":"Indian J Ophthalmol"},{"key":"5047_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40662-018-0119-9","volume":"5","author":"A Campos","year":"2018","unstructured":"Campos A, Campos EJ, Do Carmo A, Caramelo F, Martins J, Sousa JP, et al. Evaluation of markers of outcome in real-world treatment of diabetic macular edema. Eye Vis. 2018;5:27. https:\/\/doi.org\/10.1186\/s40662-018-0119-9.","journal-title":"Eye Vis"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-05047-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05047-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05047-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:01:23Z","timestamp":1789455683000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-05047-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5047"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-05047-6","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"2 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Ethics Committee of Zhongshan Hospital, Fudan University. The study was a retrospective study. All patient information was anonymized, and an exemption from informed consent was granted by the ethics committee. The study adhered to the tenets of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"575"}}